BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25319940)

  • 1. 3-Deazaneplanocin A and neplanocin A analogues and their effects on apoptotic cell death.
    Tam EK; Nguyen TM; Lim CZ; Lee PL; Li Z; Jiang X; Santhanakrishnan S; Tan TW; Goh YL; Wong SY; Yang H; Ong EH; Hill J; Yu Q; Chai CL
    ChemMedChem; 2015 Jan; 10(1):173-82. PubMed ID: 25319940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition.
    Hayden A; Johnson PW; Packham G; Crabb SJ
    Breast Cancer Res Treat; 2011 May; 127(1):109-19. PubMed ID: 20556507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells.
    Lee JK; Kim KC
    Biochem Biophys Res Commun; 2013 Sep; 438(4):647-52. PubMed ID: 23933322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Activity Relationships of Neplanocin A Analogues as S-Adenosylhomocysteine Hydrolase Inhibitors and Their Antiviral and Antitumor Activities.
    Chandra G; Moon YW; Lee Y; Jang JY; Song J; Nayak A; Oh K; Mulamoottil VA; Sahu PK; Kim G; Chang TS; Noh M; Lee SK; Choi S; Jeong LS
    J Med Chem; 2015 Jun; 58(12):5108-20. PubMed ID: 26010585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Antitumoral Effect of the S-Adenosylhomocysteine Hydrolase Inhibitor, 3-Deazaneplanocin A, is Independent of EZH2 but is Correlated with EGFR Downregulation in Chondrosarcomas.
    Aury-Landas J; Girard N; Lhuissier E; Adouane D; Delépée R; Boumediene K; Baugé C
    Cell Physiol Biochem; 2019; 53(4):731-745. PubMed ID: 31613064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRIMA-1, a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A.
    Cui B; Yang Q; Guan H; Shi B; Hou P; Ji M
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E962-70. PubMed ID: 24512488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells.
    Girard N; Bazille C; Lhuissier E; Benateau H; Llombart-Bosch A; Boumediene K; Bauge C
    PLoS One; 2014; 9(5):e98176. PubMed ID: 24852755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of halogenated 9-(dihydroxycyclopent-4'-enyl) adenines and their inhibitory activities against S-adenosylhomocysteine hydrolase.
    Jeong LS; Park JG; Choi WJ; Moon HR; Lee KM; Kim HO; Kim HD; Chun MW; Park HY; Kim K; Sheen YY
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):919-21. PubMed ID: 14565311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aristeromycin and DZNeP cause growth inhibition of prostate cancer via induction of mir-26a.
    Uchiyama N; Tanaka Y; Kawamoto T
    Eur J Pharmacol; 2017 Oct; 812():138-146. PubMed ID: 28705714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
    Cheng LL; Itahana Y; Lei ZD; Chia NY; Wu Y; Yu Y; Zhang SL; Thike AA; Pandey A; Rozen S; Voorhoeve PM; Yu Q; Tan PH; Bay BH; Itahana K; Tan P
    Clin Cancer Res; 2012 Aug; 18(15):4201-12. PubMed ID: 22675170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells.
    Tan J; Yang X; Zhuang L; Jiang X; Chen W; Lee PL; Karuturi RK; Tan PB; Liu ET; Yu Q
    Genes Dev; 2007 May; 21(9):1050-63. PubMed ID: 17437993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model.
    Akpa CA; Kleo K; Oker E; Tomaszewski N; Messerschmidt C; López C; Wagener R; Oehl-Huber K; Dettmer K; Schoeler A; Lenze D; Oefner PJ; Beule D; Siebert R; Capper D; Dimitrova L; Hummel M
    BMC Cancer; 2020 May; 20(1):427. PubMed ID: 32408898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the antiproliferative effects of 3-deazaneoplanocin A in combination with standard anticancer agents in rhabdoid tumor cell lines.
    Unland R; Borchardt C; Clemens D; Kool M; Dirksen U; Frühwald MC
    Anticancer Drugs; 2015 Mar; 26(3):301-11. PubMed ID: 25415657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for substrate recognition by a S-adenosylhomocysteine hydrolase Lpg2021 from Legionella pneumophila.
    Gao Y; Xie R; Chen Y; Yang B; Wang M; Hua L; Wang X; Wang W; Wang N; Ge H; Ma J
    Int J Biol Macromol; 2024 Jun; 270(Pt 1):132289. PubMed ID: 38735607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship of 5'-substituted fluoro-neplanocin a analogues as potent inhibitors of S-adenosylhomocysteine hydrolase.
    Moon HR; Lee KM; Lee JH; Lee SK; Park SB; Chun MW; Jeong LS
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):707-8. PubMed ID: 16248019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. John Montgomery's legacy: carbocyclic adenosine analogues as SAH hydrolase inhibitors with broad-spectrum antiviral activity.
    De Clercq E
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1395-415. PubMed ID: 16438025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel 4'-modified neplanocin A analogues and their inhibitory activity against S-adenosyl-L-l-homocysteine hydrolase.
    Kumamoto H; Deguchi K; Takahashi N; Tanaka H; Kitade Y
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):733-6. PubMed ID: 18066891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Deazaneplanocin A (DZNep), an inhibitor of S-adenosylmethionine-dependent methyltransferase, promotes erythroid differentiation.
    Fujiwara T; Saitoh H; Inoue A; Kobayashi M; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Harigae H
    J Biol Chem; 2014 Mar; 289(12):8121-34. PubMed ID: 24492606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Deazaneplanocin A is a promising therapeutic agent for ovarian cancer cells.
    Shen L; Cui J; Pang YX; Ma YH; Liu PS
    Asian Pac J Cancer Prev; 2013; 14(5):2915-8. PubMed ID: 23803053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-based proteome profiling using an affinity-based probe (AfBP) derived from 3-deazaneplanocin A (DzNep).
    Tam EK; Li Z; Goh YL; Cheng X; Wong SY; Santhanakrishnan S; Chai CL; Yao SQ
    Chem Asian J; 2013 Aug; 8(8):1818-28. PubMed ID: 23749335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.